Clinical Trials
All Clinical Trials - Page 18 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05659368Phase 2Unknown
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
Tirzepatide
- NCT06959784Phase 4Enrolling By Invitation
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
Semaglutide
- NCT06057077Phase 1/Phase 2Unknown
Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
Semaglutide
- NCT06730958N/ACompleted
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
Follistatin
- NCT06840847N/ACompleted
Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormone Agonists (LHRHa )
Gonadorelin
- NCT06145958N/ANot Yet Recruiting
Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational Study
Gonadorelin
- NCT06256419N/ARecruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
Exenatide
- NCT06772584N/ACompleted
Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06164873Phase 3Unknown
A Study of IBI362 9 mg in Chinese Adults With Obesity
Mazdutide
- NCT06401447N/AActive Not Recruiting
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
Thymosin-Alpha-1
- NCT05896384Phase 1Completed
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
Survodutide
- NCT07304141N/ACompleted
Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity
Liraglutide
- NCT07043361N/ACompleted
Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels
Semaglutide
- NCT06162559Phase 1Recruiting
Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
Gonadorelin
- NCT05341128N/ACompleted
A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China
Gonadorelin
- NCT07057622Phase 3Recruiting
A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs
Octreotide
- NCT06148649Phase 2Completed
Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
Dulaglutide
- NCT06512207N/ARecruiting
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
Gonadorelin
- NCT05140694Phase 4Unknown
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
Dulaglutide
- NCT06046417Phase 2/Phase 3Unknown
A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
Pramlintide
- NCT06131437Phase 3Completed
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
Tirzepatide
- NCT06066528Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
Survodutide
- NCT06066515Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Survodutide
- NCT06164795N/ARecruiting
Sequential Therapies After Osteoanabolic Treatment
Teriparatide
- NCT05851547Phase 2Recruiting
Dose Escalation For INtraprostatic LEsions
Gonadorelin
- NCT05932732Phase 4Completed
Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.
GHK-Cu
- NCT06077864Phase 3Completed
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
Survodutide
- NCT06143956Phase 2Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Tirzepatide
- NCT06124807Phase 2Completed
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Mazdutide
- NCT05870579Phase 1Active Not Recruiting
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Ghrp-6
- NCT06109311Phase 3Completed
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
Orforglipron
- NCT05912621Phase 2Recruiting
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
Tirzepatide
- NCT05983198Phase 1Active Not Recruiting
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
Gonadorelin
- NCT05819853Phase 3Recruiting
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
Semaglutide
- NCT06629688N/ACompleted
Semaglutide and Intestinal Iron Absorption
Semaglutide
- NCT06333080N/ATerminated
The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
Semaglutide
- NCT06142708N/AUnknown
The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger
Gonadorelin
- NCT05952882Phase 3Unknown
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
Liraglutide
- NCT06501326Phase 4Unknown
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Liraglutide
- NCT07576036N/AEnrolling By Invitation
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia
Desmopressin
- NCT06060392N/ARecruiting
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
Semaglutide
- NCT05918302Phase 3Recruiting
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Octreotide
- NCT05938712Phase 2Recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
Semaglutide
- NCT05901467Phase 1Terminated
Recall by Genotype: Neuropeptide Stimulation
Kisspeptin
- NCT05625087Phase 2Active Not Recruiting
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
Gonadorelin
- NCT06247748Phase 1Completed
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Exenatide
- NCT06085482Phase 1Completed
A Phase I Study of LY3502970 in Healthy Participants
Orforglipron
- NCT06015893Phase 2Active Not Recruiting
Semaglutide Therapy for Alcohol Reduction (STAR)
Semaglutide
- NCT06075667Phase 3Active Not Recruiting
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Tirzepatide
- NCT05788965Phase 2/Phase 3Completed
Semaglutide in CFRD
Semaglutide